Thyroid :: FDA acts to ensure thyroid drugs don’t lose potency before expiration date

The U.S. Food and Drug Administration is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other thyroid conditions, to ensure the drug retains its potency over its entire shelf life. This action is being taken in response to concerns that the potency of the drug may deteriorate prior to its expiration date.

Brain :: Brain needs perfection in synapse number

Like Goldilocks, the brain seeks proportions that are just right. The proper number of synapses or communication between nerve cells, determined early in life, is crucial to having a healthy brain that can learn and retain information.

Head and Neck Cancer :: Taxotere granted FDA approval to treat Head and Neck Cancer

Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) has approved Taxotere(R) (docetaxel) Injection Concentrate in combination with cisplatin and 5-fluorouracil for induction therapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN) before patients undergo chemoradiotherapy and surgery.

Pregnancy :: Pregnancy after breast cancer is possible

U-M expert says new cancer treatments, technologies give women more hope of preserving fertility. Once Alyssa Tushman knew her young son would not grow up motherless, her next question was whether he would be an only child.

Stress :: Carbon dioxide triggers inborn distress

PLoS ONE publishes a study showing that inhalation of carbon dioxide (CO2) triggers emotional distress and a panic response in healthy individuals. The findings of the study posit panic as an inborn survival-oriented response. The results may be relevant for a better understanding and the further prevention of emotional disorders.

Heart :: Algorithms to reanimate the heart

When an adult suffers a cardiorespiratory arrest the rapid application of an electrical discharge with a defibrillator can avoid sudden death in many cases. Nevertheless, defibrillation also has its impediment or enemy: time. For every minute that passes from the moment of the attack, the possibilities of survival drop by 10%.

Genetic :: First significant genetic finding in severe PMS, or PMDD

The first significant genetic finding in premenstrual dysphoric disorder (PMDD) has now been reported. PMDD is a very severe form of the more commonly known premenstrual syndrome, or PMS. PMDD is heritable, affects 5-8% of women, and is associated with severe emotional and physical problems, such as irritability, marked depressed mood, anger, headaches, weight gain and more, to such an extent that quality of life is seriously impacted.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack